We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.
Monkeypox is usually endemic in tropical rainforest areas of Central and West African countries, particularly the Democratic Republic of Congo and Nigeria. Most cases occur sporadically or in the context of localized outbreaks. Cases outside of endemic countries are usually associated with international travel or importation of animals infected with the monkeypox virus (MPXV).
Case definitions can be used for the purpose of monitoring monkeypox outbreaks for rapid identification of clusters and transmission routes. Case definitions commonly used for surveillance include suspected, probable, and confirmed cases of monkeypox. Suspected cases are those with clinical manifestations consistent with one and more symptoms of monkeypox. Probable cases are those with the possibility of exposure to the monkeypox transmission route on a suspected basis. Confirmed cases are individuals with laboratory-confirmed monkeypox infection.
In 1970, the first human case was identified in a 9-month-old patient in a remote village in the Democratic Republic of Congo. Since 1970, human monkeypox outbreaks and cases have been reported in several African countries. Among them, the Democratic Republic of Congo and Nigeria are the most affected countries.
Cases outside of Africa were first reported in the United States in 2003. Prior to 2022, cases outside of Africa had been reported in the United States, the United Kingdom, Israel, and Singapore. The number of cases then increased exponentially in people with no history of travel to endemic areas from 2022 when a case of monkeypox infection from a traveler returning from Nigeria was reported in the United Kingdom.
Monkeypox is an emerging disease outside of endemic countries that has rapidly spread to several countries and continents in the last few months. Timely study and analysis of monkeypox cases is essential in the face of new infectious disease challenges. This can help detect significant changes in the route of transmission, mean age, signs/symptoms of clinical presentation, and their evolution.
We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.